Detalhe da pesquisa
1.
Conflicting Effects of Wnt-5a in Ulcerative Colitis: You Wnt Some, You Lose Some.
Dig Dis Sci;
67(10): 4599-4601, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35639228
2.
Stanniocalcin-1 Promotes PARP1-Dependent Cell Death via JNK Activation in Colitis.
Adv Sci (Weinh);
11(5): e2304123, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38088577
3.
Recent developments on BMPs and their antagonists in inflammatory bowel diseases.
Cell Death Discov;
9(1): 210, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37391444
4.
Role of Rho GTPases in inflammatory bowel disease.
Cell Death Discov;
9(1): 24, 2023 Jan 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36690621
5.
Protocadherin 20 maintains intestinal barrier function to protect against Crohn's disease by targeting ATF6.
Genome Biol;
24(1): 159, 2023 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37407995
6.
A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis.
J Inflamm Res;
16: 1879-1894, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37152865
7.
Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn's disease.
Therap Adv Gastroenterol;
15: 17562848221089096, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35399190
8.
Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice.
J Inflamm Res;
15: 2523-2537, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35479832
9.
Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease.
EBioMedicine;
76: 103846, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35124427
10.
Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease.
Gastroenterol Rep (Oxf);
10: goab056, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35382172
11.
Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease.
Cell Death Discov;
7(1): 314, 2021 Oct 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34702800
12.
A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn's Disease.
Front Immunol;
12: 646673, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34367126
13.
MALAT1 Maintains the Intestinal Mucosal Homeostasis in Crohn's Disease via the miR-146b-5p-CLDN11/NUMB Pathway.
J Crohns Colitis;
15(9): 1542-1557, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33677577
14.
Serum Biomarkers for Inflammatory Bowel Disease.
Front Med (Lausanne);
7: 123, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32391365
15.
Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
Cell Death Dis;
11(6): 456, 2020 06 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32541691
16.
Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease.
Inflamm Bowel Dis;
26(11): 1636-1647, 2020 10 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33026078
17.
Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn's disease.
Therap Adv Gastroenterol;
13: 1756284820979442, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33425010
18.
Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.
Aliment Pharmacol Ther;
49(6): 733-743, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30734320
19.
Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway.
Inflamm Bowel Dis;
24(10): 2211-2223, 2018 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29788092